Cardiology consultants of Philadelphia
Yardley, Pennsylvania 19067
4 studies enrolling now · 23 studies all time
What they study most
Acute Coronary Syndrome, Arthritis, Rheumatoid, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Flutter, Bradycardia, Cardiac Arrhythmias, Cardiotoxicity, Cardiovascular Disease and Lipoprotein(a), Cardiovascular Diseases, Coronary Artery Disease, Diabetes Mellitus, Type 2
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) — Recruiting now
- A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
- Novel On-body Evaluation of Cardiac Health for Oncology — Enrolling by invitation
- Confirm Rx Insertable Cardiac Monitor SMART Registry — Completed
- Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
- A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) — Completed
- Benefits of µCor in Ambulatory Decompensated Heart Failure — Completed
- Multiple Cardiac Sensors for the Management of Heart Failure — Completed
- Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis — Completed
- St. Jude Medical Product Longevity and Performance (SCORE) Registry — Completed
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
- MultiPoint Pacing™ Post Market Study — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
- Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
- Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices — Completed
- ELEVATE (Evaluation of Left Ventricular Autothreshold) 3.0 — Completed
- Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early